Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis

被引:21
|
作者
Tse, Frances [1 ]
Yuan, Yuhong [1 ]
Bukhari, Majidah [1 ]
Leontiadis, Grigorios I. [1 ]
Moayyedi, Paul [1 ]
Barkun, Alan [2 ]
机构
[1] McMaster Univ, Dept Med, Div Gastroenterol, 1200 Main St West,2F53, Hamilton, ON L8N 3Z5, Canada
[2] Montreal Gen Hosp, Clin Epidemiol, Montreal, PQ H3G 1A4, Canada
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2016年 / 05期
关键词
COMMON BILE-DUCT; TRANSPANCREATIC PRECUT SPHINCTEROTOMY; RISK-FACTORS; SELECTIVE CANNULATION; EUROPEAN-SOCIETY; RANDOMIZED-TRIAL; DEEP CANNULATION; ESGE GUIDELINE; WIRE PLACEMENT; NEEDLE-KNIFE;
D O I
10.1002/14651858.CD010571.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Difficult cannulation is a risk factor for post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). It has been postulated that the pancreatic duct guidewire (PGW) technique may improve biliary cannulation success and reduce the risk of PEP in people with difficult cannulation. Objectives To systematically review evidence from randomised controlled trials (RCTs) assessing the effectiveness and safety of the PGW technique compared to persistent conventional cannulation (CC) (contrast-or guidewire-assisted cannulation) or other advanced techniques in people with difficult biliary cannulation for the prevention of PEP. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL databases, major conference proceedings, and for ongoing trials on the ClinicalTrials.gov and World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) up to March 2016, using the Cochrane Upper Gastrointestinal and Pancreatic Diseases model with no language restrictions. Selection criteria RCTs comparing the PGW technique versus persistent CC or other advanced techniques in people undergoing ERCP with difficult biliary cannulation. Data collection and analysis Two review authors independently conducted study selection, data extraction, and methodological quality assessment. Using intention-to-treat analysis with random-effects models, we combined dichotomous data to obtain risk ratios (RR) with 95% confidence intervals (CI). We assessed heterogeneity using the Chi(2) test (P < 0.15) and I-2 test (> 25%). To explore sources of heterogeneity, we conducted a priori subgroup analyses according to trial design, use of pancreatic duct (PD) stent, involvement of trainees in cannulation, publication type, and risk of bias. To assess the robustness of our results, we carried out sensitivity analyses using different summary statistics (RR versus odds ratio (OR)) and meta-analytic models (fixed-effect versus random-effects). Main results We included seven RCTs comprising 577 participants. There was no significant heterogeneity among trials for the outcome of PEP (P = 0.32; I-2 = 15%). The PGW technique significantly increased PEP compared to other endoscopic techniques (RR 1.98, 95% CI 1.14 to 3.42; low-quality evidence). The number needed to treat for an additional harmful outcome was 13 (95% CI 5 to 89). Among the three studies that compared the PGW technique with persistent CC, the incidence of PEP was 13.5% for the PGW technique and 8.7% for persistent CC (RR 1.58, 95% CI 0.83 to 3.01; low-quality evidence). Among the two studies that compared the PGW technique with precut sphincterotomy, the incidence of PEP was 29.8% in the PGW group versus 10.3% in the precut group (RR 2.92, 95% CI 1.24 to 6.88; low-quality evidence). Among the two studies that compared the PGW technique with PD stent placement, the incidence of PEP was 11.7% for the PGW technique and 5.0% for PD stent placement (RR 1.75, 95% CI 0.08 to 37.50; very low-quality evidence). There was no significant difference in common bile duct (CBD) cannulation success with the randomised technique (RR 1.04, 95% CI 0.87 to 1.24; low-quality evidence) or overall CBD cannulation success (RR 1.04, 95% CI 0.91 to 1.18; low-quality evidence) between the PGW technique and other endoscopic techniques. There was also no statistically significant difference in the risk of other ERCP-related complications (bleeding, perforation, cholangitis, and mortality). The results were robust in sensitivity analyses. The overall quality of evidence for the outcome of PEP was low or very low because of study limitations and imprecision. Authors' conclusions In people with difficult CBD cannulation, sole use of the PGW technique appears to be associated with an increased risk of PEP. Prophylactic PD stenting after use of the PGW technique may reduce the risk of PEP. However, the PGW technique is not superior to persistent attempts with CC, precut sphincterotomy, or PD stent in achieving CBD cannulation. The influence of co-intervention in the form of rectal peri-procedural nonsteroidal anti-inflammatory drug administration is unclear.
引用
收藏
页数:80
相关论文
共 50 条
  • [1] Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
    Tse, Frances
    Yuan, Yuhong
    Moayyedi, Paul
    Leontiadis, Grigorios I.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (12):
  • [2] Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
    Tse, Frances
    Liu, Jasmine
    Yuan, Yuhong
    Moayyedi, Paul
    Leontiadis, Grigorios, I
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (03):
  • [3] Impact of changing our cannulation method on the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis after pancreatic guidewire placement
    Hisa, Takeshi
    Matsumoto, Ryusuke
    Takamatsu, Masato
    Furutake, Masayuki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (48) : 5289 - 5294
  • [4] Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by pancreatic duct stenting using a loop-tipped guidewire
    Sakai, Yuji
    Tsuyuguchi, Toshio
    Sugiyama, Harutoshi
    Hayashi, Masahiro
    Senoo, Jun-ichi
    Sasaki, Reina
    Kusakabe, Yuko
    Nakamura, Masato
    Yasui, Shin
    Mikata, Rintaro
    Miyazaki, Masaru
    Yokosuka, Osamu
    WORLD JOURNAL OF CLINICAL CASES, 2016, 4 (08) : 213 - 218
  • [5] Pancreatic guidewire technique increases the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Fukasawa, Mitsuharu
    Takano, Shinichi
    Enomoto, Nobuyuki
    DIGESTIVE ENDOSCOPY, 2016, 28 : 102 - 103
  • [6] Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis by Pancreatic Duct Stenting: Should It Be Routine?
    Kozarek, Richard A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (10) : 810 - 812
  • [7] Endoscopic prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Lee, Tae Hoon
    Park, Do Hyun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (44) : 16582 - 16595
  • [8] Risk of pancreatitis after pancreatic duct guidewire placement during endoscopic retrograde cholangiopancreatography
    Ishikawa-Kakiya, Yuki
    Shiba, Masatsugu
    Maruyama, Hirotsugu
    Kato, Kunihiro
    Fukunaga, Shusei
    Sugimori, Satoshi
    Otani, Koji
    Hosomi, Shuhei
    Tanaka, Fumio
    Nagami, Yasuaki
    Taira, Koichi
    Yamagami, Hirokazu
    Tanigawa, Tetsuya
    Watanabe, Toshio
    Fujiwara, Yasuhiro
    PLOS ONE, 2018, 13 (01):
  • [9] Post-endoscopic retrograde cholangiopancreatography pancreatitis
    Thaker, Adarsh M.
    Mosko, Jeffrey D.
    Berzin, Tyler M.
    GASTROENTEROLOGY REPORT, 2015, 3 (01): : 32 - 40
  • [10] Risk of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Double-Guidewire Biliary Cannulation in an Average-Risk Population
    Krill, Joseph T.
    DaVee, Tomas
    Edwards, Jade S.
    Slaughter, J. Chris
    Yachimski, Patrick S.
    PANCREAS, 2018, 47 (06) : 748 - 752